Ferro Pharma

At Ferro Pharma we are changing the health care market by cutting value chains to decrease cost of drug development and drug availability. EMELEMA® - Making Latest Medicine Available – is what we believe in and what drives the best talent from around the globe to join us. Our aim is to be known as the company that increases patient access to generic and innovative medicine. We focus on building bridges between markets, stakeholders and patients. Collectively, we believe in finding the most fair, straight and reliable provider for the distribution of ingredients, medicine and services. We direct our attention on novel delivery systems, the provision of EU registered and manufactured drugs and on ingredients. Our core markets are China, Latin America and the European Union.

With exceptional growth, profit and fun we will continue to be recognized globally. We will attract the most desired talents, co-investors and strategic partners around us and will mutually enter into changing the industry for long-term benefits of all stakeholders, among which patients are our utmost priority. EMELEMA®!


Good Morning Madrid!

Good Morning Madrid!

The whole team at Ferro Pharma is looking forward to the CPHI Worldwide 2018. With excitement we will meet all our valued suppliers, customers and partners from around the globe. Come and see us at booth 5F42 – we are always eager to find new partnerships and build bridges with a focus on new developments, innovation and technology.

We are ready for the next steps...

We are ready for the next steps...

... in #innovation, #technology, #supply of #APIs and in providing #services to the #pharma industry: we at #FerroPharma just launched our new website. Check it out here

Unique drug delivery platform

Unique drug delivery platform

...keynote presentation on #Ferropharma’s #CARELA HOLDING’s latest venture, #EsoCap’s unique drug delivery platform...“The insightful discussion with the experts will allow EsoCap to rapidly move into clinical testing of our smart #drug delivery platform” said Isabelle Racamier, CEO of EsoCap AG. “Our #technology may be beneficial in at least 6 indications affecting a total of 370 Mio patients.”...read more https://www.esocapbiotech.ch/#news

More News

Signing of a long term cooperation agreement

Ferro Pharma is licensing out eight generic products

Ferro Pharma has successfully passed the audit

Our Team

Carol von Gersdorff

Christian Schulenburg

Dr. Verena Mack

Sebastian Kähler

Christian Hofmann

Lukas Bilowitzki

Magdalena Horn

Maria Lucia Rodriguez

Alexander Engler

Bettina Böttcher

Melanie Kuhagen

Get in touch


Ferro Pharma GmbH

Budapester Straße 47
20359 Hamburg (Germany)

Phone: +49 40 306868 0
Fax: +49 40 306868 33


Please do not hesitate to use our
contact form or send us an email.

Thank you!

Contact form

What is the sum of 2 and 6?